These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7660137)

  • 1. The activated megakaryocyte-platelet-system in vascular disease: focus on diabetes.
    Tschoepe D
    Semin Thromb Hemost; 1995; 21(2):152-60. PubMed ID: 7660137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelets in diabetes: the role in the hemostatic regulation in atherosclerosis.
    Tschoepe D; Roesen P; Schwippert B; Gries FA
    Semin Thromb Hemost; 1993; 19(2):122-8. PubMed ID: 8356457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Von Willebrand factor in diabetic angiopathy.
    Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
    Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Platelet aggregation inhibitors in diabetes mellitus].
    Abrahamian H
    Acta Med Austriaca; 1999; 26(5):137-41. PubMed ID: 11512189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinically apparent atherosclerotic disease in diabetes is associated with an increase in platelet microparticle levels.
    Tan KT; Tayebjee MH; Lim HS; Lip GY
    Diabet Med; 2005 Dec; 22(12):1657-62. PubMed ID: 16401308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of calpain in diabetes-associated platelet hyperactivation.
    Randriamboavonjy V; Fleming I
    Adv Pharmacol; 2010; 59():235-57. PubMed ID: 20933204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus.
    Omoto S; Nomura S; Shouzu A; Nishikawa M; Fukuhara S; Iwasaka T
    Diabetologia; 2002 Apr; 45(4):550-5. PubMed ID: 12032632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart disease in diabetes mellitus: a challenge for early diagnosis and intervention.
    Tschoepe D; Roesen P
    Exp Clin Endocrinol Diabetes; 1998; 106(1):16-24. PubMed ID: 9516054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets and antiplatelet therapy in patients with diabetes mellitus.
    Arjomand H; Roukoz B; Surabhi SK; Cohen M
    J Invasive Cardiol; 2003 May; 15(5):264-9. PubMed ID: 12730635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanisms of macrovascular involvement in diabetic subjects].
    Capron L
    Diabete Metab; 1994 Nov; 20(3 Pt 2):357-61. PubMed ID: 7828780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial?
    Serebruany V; Malinin A; Pokov A; Arora U; Atar D; Angiolillo D
    Thromb Res; 2007; 119(2):175-81. PubMed ID: 16546241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the use of glycoprotein IIb/IIIa antagonists--the diabetic patient.
    Meier-Ewert HK; Nesto RW
    Rev Cardiovasc Med; 2002; 3 Suppl 1():S20-7. PubMed ID: 12439433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
    Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
    Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albuminuria--a marker of renal and generalized vascular disease in insulin-dependent diabetes mellitus.
    Jensen T
    Dan Med Bull; 1991 Apr; 38(2):134-44. PubMed ID: 2060321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diabetes, coagulation and vascular events].
    Nenci GG; Paliani U
    Recenti Prog Med; 2000 Feb; 91(2):86-90. PubMed ID: 10748654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
    Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alterations of platelet membrane glycoproteins in patients with diabetes mellitus and their clinical significance].
    Han Y; Wang Z; Wang A
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):127-9. PubMed ID: 11601237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombotic complications in essential thrombocythemia (ET): clinical facts and biochemical riddles.
    Petrides PE; Siegel F
    Blood Cells Mol Dis; 2006; 36(3):379-84. PubMed ID: 16563815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood viscosity and thrombosis: clinical considerations.
    Smith BD; La Celle PL
    Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.